www.fdanews.com/articles/175990-philips-mr-only-simulation-nabs-fda-clearance
![](https://www.fdanews.com/ext/resources/test/Device_Images4/FDA_Logo_Large.gif?t=1486528488&width=430)
Philips’ MR-Only Simulation Nabs FDA Clearance
April 1, 2016
The FDA has granted Philips a 510(k) clearance for its MR-only MRCAT, designed for prostate cancer radiation treatment planning, the company announced Wednesday.
Compared to the MR-CT approach, the MR-only solution removes the risk of image misalignment and registration uncertainties. The MR-only approach alleviates the need for additional patient scans.
The simulation is a part of the company’s Ingenia MR-RT platform, and let’s physicians rely on a single-modality imaging approach. — Anisa Jibrell